Loading provider…
Loading provider…
Hematology & Oncology Physician in Santa Maria, CA
NPI: 1053567545Primary Practice Location
Mission Hope Medical Oncology - Santa Maria
1325 E Church St, Santa Maria, CA
Primary Employer
Mission Hope Medical Oncology - Santa Maria
dignityhealth.org
HQ Phone
Get MD Wei's Phone Numberphone_androidMobile
Get MD Wei's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOR State Medical License
CA State Medical License
2019 - 2025
OR State Medical License
2011 - 2023
DC State Medical License
2008 - 2013

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
MedStar Health Georgetown University
Fellowship • Hematology and Medical Oncology
2008 - 2011
New York Downtown Hospital
Residency • Internal Medicine
2005 - 2008
Beijing Medical University
Medical School
Until 1995
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 213 | 817 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 125 | 178 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 81 | 171 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 37 | 37 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 29 | 29 |
Authors: Bai, Wei, Wu, Zheqiong, Mitra, Somenath, Brown, Jared M
Journal: J Nanomater
Regulation of 12-lipoxygenase by platelet-derived growth factor in vascular smooth muscle cells.
Authors: Natarajan, R, Bai, W, Gu, J, Rangarajan, V, Nadler, J
Journal: Adv Prostaglandin Thromboxane Leukot Res
Authors: Natarajan, R, Bai, W, Lanting, L, Gonzales, N, Nadler, J
Journal: Am J Physiol
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, DRUG: Sunitinib Malate, BIOLOGICAL: Nivolumab, OTHER: Laboratory Biomarker Analysis, DRUG: Osimertinib, PROCEDURE: Biospecimen Collection, DRUG: Dabrafenib, DRUG: Crizotinib, DRUG: Sapanisertib, DRUG: Taselisib, PROCEDURE: Computed Tomography, BIOLOGICAL: Trastuzumab, DRUG: Trametinib, PROCEDURE: Multigated Acquisition Scan, DRUG: Palbociclib, DRUG: Afatinib, DRUG: Ulixertinib, OTHER: Cytology Specimen Collection Procedure, DRUG: Dasatinib, DRUG: Vismodegib, DRUG: Afatinib Dimaleate, DRUG: Adavosertib, PROCEDURE: Biopsy Procedure, DRUG: Defactinib, PROCEDURE: Radionuclide Imaging, BIOLOGICAL: Trastuzumab Emtansine, DRUG: Copanlisib, PROCEDURE: Echocardiography Test, DRUG: PI3K-beta Inhibitor GSK2636771, DRUG: Larotrectinib, BIOLOGICAL: Relatlimab, DRUG: Copanlisib Hydrochloride, DRUG: Capivasertib, DRUG: Erdafitinib, DRUG: Larotrectinib Sulfate, DRUG: Binimetinib, BIOLOGICAL: Pertuzumab, DRUG: Ipatasertib, DRUG: Dabrafenib Mesylate, DRUG: Defactinib Hydrochloride, DRUG: Fexagratinib, PROCEDURE: Radiologic Examination